In this article, we will explore the topic of Rescinnamine from different perspectives and approaches. Rescinnamine is a very important issue today, as it affects a wide spectrum of people and contexts. Over the next few lines, we will analyze the importance of Rescinnamine, its impact on society and some possible solutions or approaches to address this issue effectively. Through reflection and critical analysis, we will seek to better understand Rescinnamine and its relevance in everyday life.
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Moderil, Cinnasil, Anaprel |
Other names | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{oxy}-3,13-diazapentacyclohenicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.042.232 |
Chemical and physical data | |
Formula | C35H42N2O9 |
Molar mass | 634.726 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Rescinnamine, known by the brand names Moderil, Cinnasil, and Anaprel, is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is an indoloquinolizine alkaloid similar to reserpine, obtained from Rauvolfia serpentina[1] and other species of Rauvolfia.[2]